TABLE 4.
Model 1 OR [95% CI]; p-value | Model 2 OR [95% CI]; p-value | Model 3 OR [95% CI]; p-value | |
OSA severity | |||
15 ≥ AHI > 30/h | 1.25 [0.72–2.16]; p = 0.43 | 1.06 [0.60–1.89]; p = 0.83 | 1.20 [0.67–2.15]; p = 0.54 |
AHI ≥ 30/h | 1.86 [0.99–3.48]; p = 0.05 | 1.44 [0.74–2.82]; p = 0.28 | 1.97 [0.84–4.63]; p = 0.24 |
Gender (Male) | 1.18 [0.72–1.93]; p = 0.50 | 1.78 [0.67–4.69]; p = 0.24 | 1.43 [0.54–3.85]; p = 0.47 |
BMI (≥30 kg/m2) | 2.84 [1.40–5.73]; p = 0.004 | 1.85 [0.80–4.28]; p = 0.15 | 1.97 [0.84–4.63]; p = 0.12 |
DXA | |||
Trunk fat mass (%) | 1.06 [0.94–1.17]; p = 0.38 | 1.01 [0.90–1.13]; p = 0.85 | |
Body fat mass (%) | 1.003 [0.88–1.15]; p = 0.96 | 1.03 [0.90–1.18]; p = 0.70 | |
Biology | |||
Blood glucose (g/L) | 4.69 [1.12–192.78]; p = 0.04 | ||
Triglycerides (g/L) | 1.61 [1.10–2.36]; p = 0.01 |
BMI, body mass index; DXA, dual-energy X-ray absorptiometry. All significant variables are in bold.